H7N9: preparing for the unexpected in influenza
- PMID: 25386931
- DOI: 10.1146/annurev-med-010714-112311
H7N9: preparing for the unexpected in influenza
Abstract
In the years prior to 2013, avian influenza A H7 viruses were a cause of significant poultry mortality; however, human illness was generally mild. In March 2013, a novel influenza A(H7N9) virus emerged in China as an unexpected cause of severe human illness with 36% mortality. Chinese and other public health officials responded quickly, characterizing the virus and identifying more than 400 cases through use of new technologies and surveillance tools made possible by past preparedness and response efforts. Genetic sequencing, glycan-array receptor-binding assays, and ferret studies reveal the H7N9 virus to have increased binding to mammalian respiratory cells and to have mutations associated with higher virus replication rates and illness severity. New risk-assessment tools indicate H7N9 has the potential for further mammalian adaptation with possible human-to-human transmission. Vigilant virologic and epidemiologic surveillance is needed to monitor H7N9 and detect other unexpected novel influenza viruses that may emerge.
Keywords: emerging infection; preparedness; risk assessment; sequencing.
Similar articles
-
Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.J Virol. 2018 Dec 10;93(1):e01740-18. doi: 10.1128/JVI.01740-18. Print 2019 Jan 1. J Virol. 2018. PMID: 30305359 Free PMC article.
-
Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human.Sci China Life Sci. 2013 Jun;56(6):485-92. doi: 10.1007/s11427-013-4491-3. Epub 2013 May 8. Sci China Life Sci. 2013. PMID: 23657795
-
A returning migrant worker with avian influenza A (H7N9) virus infection in Guizhou, China: a case report.J Med Case Rep. 2015 May 12;9:109. doi: 10.1186/s13256-015-0580-1. J Med Case Rep. 2015. PMID: 25962780 Free PMC article.
-
Avian influenza A (H7N9) virus infection in humans: epidemiology, evolution, and pathogenesis.Infect Genet Evol. 2014 Dec;28:304-12. doi: 10.1016/j.meegid.2014.10.016. Epub 2014 Oct 24. Infect Genet Evol. 2014. PMID: 25446940 Review.
-
Novel human H7N9 influenza virus in China.Integr Zool. 2014 Jun;9(3):372-5. doi: 10.1111/1749-4877.12047. Integr Zool. 2014. PMID: 24952971 Review.
Cited by
-
Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.Med Rev (2021). 2022 Apr 26;2(2):169-196. doi: 10.1515/mr-2021-0021. Epub 2022 May 25. Med Rev (2021). 2022. PMID: 35862507 Free PMC article. Review.
-
Host variations in SARS-CoV-2 infection.Turk J Biol. 2021 Aug 30;45(4):404-424. doi: 10.3906/biy-2104-67. eCollection 2021. Turk J Biol. 2021. PMID: 34803443 Free PMC article. Review.
-
Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-2.Acta Naturae. 2021 Jul-Sep;13(3):77-88. doi: 10.32607/actanaturae.11337. Acta Naturae. 2021. PMID: 34707899 Free PMC article.
-
Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.Front Med. 2021 Aug;15(4):507-527. doi: 10.1007/s11684-020-0814-5. Epub 2021 Apr 16. Front Med. 2021. PMID: 33860875 Free PMC article. Review.
-
Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection.NPJ Vaccines. 2020 Jul 9;5(1):57. doi: 10.1038/s41541-020-0206-5. eCollection 2020. NPJ Vaccines. 2020. PMID: 32665862 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
